By vgreene, 22 June, 2015 Monitor ALT/AST, HBsAg, HBeAg, HBV DNA levels, renal function<sup>20</sup> and adherence annually [S/M]; exceptions:
By vgreene, 22 June, 2015 Entecavir:<sup>19</sup> 0.5 mg PO daily if compensated liver dz and lamivudine naïve; 1 mg PO daily if decompensated liver dz [S/M]
By vgreene, 22 June, 2015 Treat w/ nucleos(t)ide analogues<sup>13,14</sup> w/ high drug resistance barrier<sup>15</sup> [S/M]; options:
By vgreene, 22 June, 2015 Monitor ALT/AST, HBsAg, HBeAg, HBV DNA levels, and assess for cirrhosis annually [S/M]; exceptions:
